Año: 2022
Journal Impact Factor (JIF): 5,6
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 66/285 | Q1 | T1 | D3 |
| CHEMISTRY, MULTIDISCIPLINARY | SCIE | 52/178 | Q2 | T1 | D3 |
Año: 2022
Journal Citation Indicator (JCI): 0,710
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 142/315 | Q2 | T2 | D5 | 55,08 |
| CHEMISTRY, MULTIDISCIPLINARY | 77/230 | Q2 | T1 | D4 | 66,74 |
Año:
2022
CiteScore:
7,800
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Computer Science Applications | 137/792 | Q1 | T1 | D2 |
| Inorganic Chemistry | 10/78 | Q1 | T1 | D2 |
| Organic Chemistry | 29/197 | Q1 | T1 | D2 |
| Physical and Theoretical Chemistry | 31/185 | Q1 | T1 | D2 |
| Spectroscopy | 12/75 | Q1 | T1 | D2 |
| Molecular Biology | 125/380 | Q2 | T1 | D4 |
| Catalysis | 25/64 | Q2 | T2 | D4 |
SJR año:
2022
Factor de Impacto:
1,154
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Inorganic Chemistry | 7/80 | Q1 | T1 | D1 |
| Spectroscopy | 7/78 | Q1 | T1 | D1 |
| Computer Science Applications | 133/791 | Q1 | T1 | D2 |
| Medicine (miscellaneous) | 366/2531 | Q1 | T1 | D2 |
| Organic Chemistry | 21/194 | Q1 | T1 | D2 |
| Physical and Theoretical Chemistry | 25/190 | Q1 | T1 | D2 |
| Catalysis | 18/63 | Q2 | T1 | D3 |
| Molecular Biology | 136/432 | Q2 | T1 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| European Union (Euronanomed programme, Reference: TARBRAINFECT) | - |
| Health Carlos III as the local management institution | AC18/00008 |
| Ministry of Education, Culture and Sport | FPU 17/05413; FPU 16/05822; FPU 20/03952 |
| Ministry of Science, Innovation and Universities from Spain | PID2020-120481RB-I00 |
| University of Almeria | FPI-201102; PPUENTE2021-006 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Ortiz-Gonzalez, M | Universidad de Almeria; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 2 | Pérez-Victoria, I | Fdn MEDINA (Spain) |
| 3 | Ramirez-Macias, I | Hospital Universitario Virgen de las Nieves; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 4 | de Pedro, N | Fdn MEDINA (Spain) |
| 5 | Linde-Rodriguez, A | Hospital Universitario Virgen de las Nieves; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 6 | González-Menéndez, V | Fdn MEDINA (Spain) |
| 7 | Sanchez-Martin, V | Hospital Universitario Virgen de las Nieves; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 8 | Martín, J | Fdn MEDINA (Spain) |
| 9 | Soriano-Lerma, A | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research; University of Granada Faculty of Pharmacy (Spain) |
| 10 | Genilloud, O | Fdn MEDINA (Spain) |
| 11 | Perez-Carrasco, V | Hospital Universitario Virgen de las Nieves; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 12 | Vicente, F | Fdn MEDINA (Spain) |
| 13 | Maceira, J | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 14 | Rodrígues-Poveda, CA | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 15 | Navarro-Marí, JM | Hospital Universitario Virgen de las Nieves (Spain) |
| 16 | Reyes, F | Fdn MEDINA (Spain) |
| 17 | Soriano, M | Universidad de Almeria; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
| 18 | Hospital Universitario Virgen de las Nieves; Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
